Number of unsuccessful lung cancer drugs in the United States from 1998 to 2014

Loading statistic...
Number of drugs no longer under development
19982
19994
20003
20014
20028
20034
200411
20057
20066
200725
200815
200911
201014
201113
201211
201323
20146
© Statista 2017

Show further information

Complete Source Details

AdvertisementTableau Software
 
About This Statistic

This statistic depicts the number of unsuccessful lung cancer drugs that were developed in the United States from 1998 to 2014. In 2011, there were 13 unsuccessfully developed lung cancer drugs. Since 1998, there have been 167 total medicines being developed for lung cancer that were discontinued, suspended, or had no development reported and 10 approved medications.

Special Functions
Download as ...
Graphic (PNG)
Excel (XLS)
PowerPoint (PPT)
PDF
Options
Settings
Print
Research Alerts
Download started
Please be patient - this may take a moment

Statista Accounts: Access All Statistics. Starting from $588 / Year

Statistics on "Generics and biosimilars"

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statista for Your Company: The Research and Analysis Tool

  • Product Film
  • Statistics
  • Downloads

Our Premium Statistics - facts for your business

Currently, Statista provides more than 1 million statistics. 93 percent (all Premium content) are exclusively accessible via our professional accounts.

Unlimited access

As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.

You are in good company

Further Content: Statistics, Studies, and Topic Pages

Our Business Solutions: Save Time and Money

only

$588*

per year
Your advantages
  • Full access to all our statistics
  • Download as XLS, PDF & PNG
  • Relevant data: complete source information
All functions of our platform illustrated face-to-face
  • Learn how Statista supports your company
  • Extensive tour across the whole portal
  • Personal guidance by our support team
The knowledge database for your company
  • All functions of the Premium Account
  • Access to dossiers, forecasts and studies
  • Access to our international database
  • Publishing rights and other exclusive functions